日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Next-Generation Sequencing for HLA Genotype Screening and Matching to HLA-Restricted Therapies

用于HLA基因型筛查和HLA限制性疗法匹配的下一代测序

Gormally, Michael V; Chen, Monica F; Noronha, Anne Marie; Panageas, Kristalla; Reynolds, Maggie; Kohlasch, Kaelyn; Novak, Bryan; Kee-Velez, Tatiana; Clarke, Nikeysha; Eubank, Michael; Chu, Cynthia; Wilhelm, Clare; Blouin, Amanda; Kyi, Chrisann; Friedman, Claire; Rudin, Charles M; Kris, Mark G; Shah, Ronak; Aggen, David; D'Angelo, Sandra; Shoushtari, Alexander N; Berger, Michael F; Bandlamudi, Chaitanya; Klebanoff, Christopher A; Drilon, Alexander; Schoenfeld, Adam J; Donoghue, Mark T A

Barriers to publishing early phase clinical trials: the oncologists' perspective

早期临床试验发表的障碍:肿瘤学家的视角

Lucassen, Merel J J; Bergmann, Pedro; Husson, Olga; Banerji, Udai; Basu, Bristi; Melero, Ignacio; Calvo, Emiliano; Cassier, Philippe A; Drilon, Alexander; Fong, Peter C; Garralda, Elena; Joshua, Anthony M; Lin, Chia-Chi; Lopez, Juanita; Moreno, Victor; Minchom, Anna; Plummer, Ruth; Postel-Vinay, Sophie; Spreafico, Anna; Shimizu, Toshio; Yap, Timothy A; Yap, Christina; De Bono, Johann S; Steeghs, Neeltje

Enrichment of kinase fusions in ESR1 wild-type, metastatic breast cancer revealed by a systematic analysis of 4854 patients

通过对 4854 名患者的系统分析发现,ESR1 野生型转移性乳腺癌中激酶融合的富集

D S Ross, B Liu, A M Schram, P Razavi, S M Lagana, Y Zhang, M Scaltriti, J F Bromberg, M Ladanyi, D M Hyman, A Drilon, A Zehir, R Benayed, S Chandarlapaty, J F Hechtman

Selective RET kinase inhibition for patients with RET-altered cancers

针对 RET 变异癌症患者的选择性 RET 激酶抑制

V Subbiah, V Velcheti, B B Tuch, K Ebata, N L Busaidy, M E Cabanillas, L J Wirth, S Stock, S Smith, V Lauriault, S Corsi-Travali, D Henry, M Burkard, R Hamor, K Bouhana, S Winski, R D Wallace, D Hartley, S Rhodes, M Reddy, B J Brandhuber, S Andrews, S M Rothenberg, A Drilon